Clinical Trials Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Mar 27, 2023; 15(3): 430-439
Published online Mar 27, 2023. doi: 10.4240/wjgs.v15.i3.430
Table 1 The baseline characteristic analysis of the patients
Variables
Non-EIPL group, n = 75
EIPL group, n = 75
P value
Age in yr66.93 ± 9.3864.55 ± 8.220.099
Sex0.200
Male5158
Female2417
BMI in kg/m221.51 ± 2.2921.64 ± 3.340.786
Smoking status0.373
Yes5550
No2025
Tumor location0.260
Upper2114
Middle1117
Low4344
Differentiated grade0.121
High00
Middle5545
Low2030
T stage0.405
T342
T47173
N stage0.112
N01324
N11812
N21417
N33022
Tumor size in cm5.52 ± 2.215.37 ± 2.320.671
Borrmann classification0.100
II 714
III6861
CEA in g/L16.21 ± 78.0614.13 ± 35.880.834
Neutrophil count as 109/L3.49 ± 1.324.71 ± 8.390.215
Lymphocyte count as 109/L1.35 ± 0.471.76 ± 2.480.164
NLR3.02 ± 1.963.03 ± 2.200.989
Platelet as 109/L202.52 ± 61.39226.19 ± 90.940.064